Pharmaceutical composition for preventing and/or treating novel coronavirus pneumonia as well as preparation method and application thereof
The invention relates to a pharmaceutical composition for preventing and/or treating novel coronavirus pneumonia as well as a preparation method and application thereof. The pharmaceutical compositionis composed of 17 raw material medicines such as semen persicae, flos carthami, rhizoma sparganii, rhizoma curcumae, herba rhodiolae and the like. The pharmaceutical composition has a good treatmenteffect on the novel coronavirus pneumonia and can inhibit the trend of converting the common novel coronavirus pneumonia into the severe/critical novel coronavirus pneumonia; and after the pharmaceutical composition is taken, the cure and hospital discharge rate of severe/critical patients reaches up to 79.7%, and the total cure and hospital discharge rate of the severe/critical patients reaches up to 80.1%. The pharmaceutical composition can also shorten the fever course of the patients, reduce the hospitalization days of the patients and reduce the total cost. The pharmaceutical compositiondisclosed by the invention has a very good application prospect in preparation of drugs for preventing and/or treating the novel coronavirus pneumonia..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 29. Dez. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HU XIAOYU [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-12-29, Last update posted on www.tib.eu: 2022-04-10, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN112138133 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA01148179X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA01148179X | ||
| 003 | DE-627 | ||
| 005 | 20230504090810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210601s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA01148179X | ||
| 035 | |a (EPA)CN112138133 | ||
| 035 | |a (EPA)73954768 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HU XIAOYU |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmaceutical composition for preventing and/or treating novel coronavirus pneumonia as well as preparation method and application thereof |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-12-29, Last update posted on www.tib.eu: 2022-04-10, Last updated: 2023-02-09 | ||
| 520 | |a The invention relates to a pharmaceutical composition for preventing and/or treating novel coronavirus pneumonia as well as a preparation method and application thereof. The pharmaceutical compositionis composed of 17 raw material medicines such as semen persicae, flos carthami, rhizoma sparganii, rhizoma curcumae, herba rhodiolae and the like. The pharmaceutical composition has a good treatmenteffect on the novel coronavirus pneumonia and can inhibit the trend of converting the common novel coronavirus pneumonia into the severe/critical novel coronavirus pneumonia; and after the pharmaceutical composition is taken, the cure and hospital discharge rate of severe/critical patients reaches up to 79.7%, and the total cure and hospital discharge rate of the severe/critical patients reaches up to 80.1%. The pharmaceutical composition can also shorten the fever course of the patients, reduce the hospitalization days of the patients and reduce the total cost. The pharmaceutical compositiondisclosed by the invention has a very good application prospect in preparation of drugs for preventing and/or treating the novel coronavirus pneumonia. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a CHEN JING |4 aut | |
| 700 | 0 | |a LUO JIANXING |4 aut | |
| 700 | 0 | |a LIU HAI |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 29. Dez. |
| 773 | 1 | 8 | |g year:2020 |g day:29 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/73954768/publication/CN112138133A1?q=CN112138133 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2020 |b 29 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 29 |c 12 | ||